Opportunity Information: Apply for PA 08 127

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Prescription Drug Misuse (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Dec 5, 2008 and posted on Apr 3, 2008.
  • Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Independent school districts.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession
Apply for PA 08 127

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Prescription Drug Misuse (R01) funding opportunity (PA 08-127) is a National Institutes of Health (NIH) research grant announcement led by the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH). Its central goal is to support research that reduces the misuse of prescription medications while still protecting and enabling appropriate medical use of therapeutic drugs that have abuse potential. In other words, the program is not aimed at limiting legitimate pain care or psychiatric treatment; it is aimed at understanding and preventing nonmedical use, diversion, risky patterns of use, and the downstream harms that can occur when controlled or abusable prescription drugs are misused.

The scope is intentionally broad and encourages multiple types of research approaches. One major area is epidemiologic research that clarifies how large the prescription drug misuse problem is, what forms it takes, and how it varies by specific medication classes and populations. This includes studies that map out patterns of initiation and progression, determinants and risk factors, and trajectories over time, as well as the physical health, mental health, and social consequences associated with misuse. The intent is to produce clearer, drug-specific and population-specific understanding of where, how, and why misuse occurs, rather than treating prescription drug misuse as a single uniform phenomenon.

A second major area emphasized is basic science research focused on mechanisms of action. The announcement highlights interest in cellular-level and mechanistic work that explains how these drugs produce reinforcing or addictive effects, what biological pathways contribute to abuse liability, and what strategies might block, reduce, or counteract those effects. This can include investigations of potential pharmacologic approaches or medication strategies that might lessen abuse potential while maintaining therapeutic benefit. The overarching theme is to generate mechanistic knowledge that can lead to safer therapies or improved interventions.

A third area is health services and clinical research aimed at practical solutions in real-world settings. The opportunity encourages studies designed to identify effective clinical practices for detecting patients at risk of misuse, improving screening and assessment, and developing, testing, and disseminating prevention and treatment interventions. This can span work in healthcare delivery systems, prescribing environments, behavioral health settings, and community-linked care models, with an emphasis on interventions that can be adopted and sustained beyond the research setting.

The mechanism of support is the NIH Research Project Grant (R01), which is typically used for more mature, hypothesis-driven projects with substantial scope. The announcement notes that it runs in parallel with companion opportunities of the same scientific scope using different mechanisms: PA 08-128 for the R21 (often used for exploratory or developmental projects) and PA 08-129 for the R03 (often used for small, short-term projects). This structure allows applicants to choose a mechanism aligned with the maturity and scale of their proposed research while targeting the same overall program goals.

Funding under this opportunity is discretionary and depends on the availability of appropriated funds as well as the volume and quality of applications received; there is no guaranteed number of awards specified. There is also no cost sharing or matching requirement, which is typical for many NIH research grants.

Eligibility is expansive and includes a wide range of domestic and non-domestic applicants. Eligible entities include public and private institutions of higher education, state and local governments (including counties, cities/townships, special districts, and independent school districts), nonprofit organizations with or without 501(c)(3) status, for-profit organizations (including small businesses), public housing authorities/Indian housing authorities, tribal governments (federally recognized and other tribal organizations), and a variety of special categories such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. Foreign organizations are also listed as eligible, reflecting NIH's openness to high-value research contributions from outside the United States when allowed under NIH policy.

Administratively, the opportunity was posted on April 3, 2008, with a closing date of May 7, 2011, and an archive date of June 7, 2011. It is cataloged under CFDA numbers 93.242 (Mental Health Research Grants) and 93.279 (Drug Abuse and Addiction Research Programs). The full announcement was historically available through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PA-08-127.html, and NIH provided standard contact support through the NIH Office of Extramural Research (OER) webmaster for access and linking issues.

Overall, PA 08-127 is best understood as a comprehensive NIH call for research that spans from population-level surveillance and causal inference, to biological mechanisms and medication development, to healthcare delivery improvements and intervention dissemination, all focused on reducing prescription drug misuse while preserving appropriate therapeutic access.

FAQs: Prescription Drug Misuse (R01) - NIH (PA 08-127)

What is the Prescription Drug Misuse (R01) funding opportunity (PA 08-127)?

PA 08-127 is a National Institutes of Health (NIH) research grant announcement for the R01 mechanism focused on prescription drug misuse. It supports research designed to reduce nonmedical use, diversion, risky patterns of use, and related harms involving prescription medications that have abuse potential, while preserving appropriate medical use.

Which NIH Institutes lead this opportunity?

The opportunity is led by the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH).

What is the main goal of PA 08-127?

The central goal is to support research that reduces misuse of prescription medications without restricting legitimate pain care or psychiatric treatment. The focus is on preventing and understanding misuse and its consequences, not on limiting appropriate prescribing for valid medical needs.

Is this program intended to limit legitimate medical use of controlled or abusable medications?

No. The program is explicitly aimed at understanding and preventing nonmedical use and diversion and reducing downstream harms, while protecting and enabling appropriate therapeutic use.

What kinds of research topics are included in the scope?

The scope is intentionally broad and encourages multiple research approaches, including epidemiologic research, basic science/mechanistic research, and health services/clinical research aimed at practical solutions in real-world settings.

What types of epidemiologic research does PA 08-127 encourage?

The announcement emphasizes epidemiologic studies that clarify the size and nature of the prescription drug misuse problem, how it varies by medication class and population, and how patterns develop over time. This includes work on initiation and progression, determinants and risk factors, trajectories, and physical health, mental health, and social consequences.

Does the opportunity encourage drug-specific and population-specific research?

Yes. A stated intent is to develop clearer, drug-specific and population-specific understanding of where, how, and why misuse occurs, rather than treating prescription drug misuse as one uniform issue.

What basic science research is highlighted?

The announcement highlights cellular-level and mechanistic research that explains how certain prescription drugs produce reinforcing or addictive effects, what biological pathways contribute to abuse liability, and what strategies might block, reduce, or counteract those effects.

Can projects include strategies to reduce abuse potential while preserving therapeutic benefits?

Yes. The scope includes investigations of pharmacologic approaches or medication strategies that might lessen abuse potential while maintaining therapeutic benefit.

What health services and clinical research areas are encouraged?

PA 08-127 encourages studies that identify effective clinical practices for detecting patients at risk of misuse, improving screening and assessment, and developing, testing, and disseminating prevention and treatment interventions, especially those that can be adopted and sustained beyond the research setting.

What kinds of real-world settings are relevant for health services or clinical studies?

Relevant settings can include healthcare delivery systems, prescribing environments, behavioral health settings, and community-linked care models, with an emphasis on approaches that work in practice and can be sustained.

What is the funding mechanism for PA 08-127?

The mechanism of support is the NIH Research Project Grant (R01), typically used for mature, hypothesis-driven projects with substantial scope.

Are there companion opportunities with the same scientific scope but different grant mechanisms?

Yes. The announcement runs in parallel with companion opportunities covering the same scientific scope: PA 08-128 for the R21 mechanism (often exploratory/developmental) and PA 08-129 for the R03 mechanism (often small/short-term).

How should an applicant choose between R01, R21, and R03 for this topic area?

Based on the information provided, the structure is intended to let applicants select a mechanism aligned with the maturity and scale of their proposed research while pursuing the same overall program goals.

Is there a guaranteed number of awards?

No. Funding is discretionary and depends on the availability of appropriated funds and the volume and quality of applications received. No specific number of awards is specified.

Is cost sharing or matching required?

No. There is no cost sharing or matching requirement described for this opportunity.

Who is eligible to apply?

Eligibility is broad and includes domestic and non-domestic applicants, with eligible entities including (among others) public and private institutions of higher education; state and local governments; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (including small businesses); public housing authorities/Indian housing authorities; tribal governments (federally recognized and other tribal organizations); and U.S. territories or possessions.

Are foreign (non-U.S.) organizations eligible?

Yes. Foreign organizations are listed as eligible, reflecting NIH openness to research contributions from outside the United States when allowed under NIH policy.

Are specific institution types (like HBCUs or Hispanic-serving institutions) included in eligibility?

Yes. The eligibility description includes special categories such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations, among others.

When was this funding opportunity posted?

It was posted on April 3, 2008.

What were the closing and archive dates for PA 08-127?

The closing date was May 7, 2011, and the archive date was June 7, 2011.

What CFDA numbers are associated with this opportunity?

The opportunity is cataloged under CFDA 93.242 (Mental Health Research Grants) and 93.279 (Drug Abuse and Addiction Research Programs).

Where was the full announcement historically posted?

The full announcement was historically available through the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PA-08-127.html.

Who was listed as a contact for access or linking issues?

NIH provided standard contact support through the NIH Office of Extramural Research (OER) webmaster for access and linking issues.

What is the overall focus of PA 08-127 in plain terms?

Overall, PA 08-127 is a comprehensive NIH call for research spanning population-level surveillance and causal inference, biological mechanisms and medication strategies, and healthcare delivery improvements and dissemination of interventions, all aimed at reducing prescription drug misuse while preserving appropriate therapeutic access.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Prescription Drug Misuse (R21)

Previous opportunity: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 127

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 127) also looked into and applied for these:

Funding Opportunity
Prescription Drug Misuse (R21) Apply for PA 08 128

Funding Number: PA 08 128
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Prescription Drug Misuse (R03) Apply for PA 08 129

Funding Number: PA 08 129
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploratory/Developmental Grant for Complementary and Alternative Medicine (CAM) Studies of Humans (R21) Apply for PAR 08 135

Funding Number: PAR 08 135
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Correlative Studies with Specimens from Multi Site Trials (R21) Apply for PA 08 133

Funding Number: PA 08 133
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Correlative Studies with Specimens from Multi Site Trials (R01) Apply for PA 08 134

Funding Number: PA 08 134
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01) Apply for PA 08 143

Funding Number: PA 08 143
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) Apply for PA 08 144

Funding Number: PA 08 144
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Science Education Drug Abuse Partnership Award R25 Apply for PAR 08 145

Funding Number: PAR 08 145
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomarkers of Infection Associated Cancers (R01) Apply for PA 08 156

Funding Number: PA 08 156
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomarkers of Infection Associated Cancers (R21) Apply for PA 08 157

Funding Number: PA 08 157
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Transdisciplinary Research on Fatigue and Fatigability in Aging (R01) Apply for PA 08 161

Funding Number: PA 08 161
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Transdisciplinary Research on Fatigue and Fatigability in Aging (R21) Apply for PA 08 162

Funding Number: PA 08 162
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Stem Cells and Cancer (R21) Apply for PA 08 165

Funding Number: PA 08 165
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R03) Apply for PA 08 172

Funding Number: PA 08 172
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R01) Apply for PA 08 174

Funding Number: PA 08 174
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Novel Lentiviral Models of HIV Neuropathogenesis (R01) Apply for PAS 08 178

Funding Number: PAS 08 178
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Novel Lentiviral Models of HIV Neuropathogenesis (R21) Apply for PAS 08 179

Funding Number: PAS 08 179
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Exploratory/Developmental Grant for Complementary and Alternative Medicine (CAM) Studies using Cells, Tissues, and Animal Models of Disease (R21) Apply for PA 08 185

Funding Number: PA 08 185
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Medications Development for Polydrug Addiction Treatment (R01) Apply for PAS 08 186

Funding Number: PAS 08 186
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for Polydrug Addiction Treatment (R21) Apply for PAS 08 187

Funding Number: PAS 08 187
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 127", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.